58 related articles for article (PubMed ID: 30333087)
1. Predictive value of the G8 screening tool for postoperative complications in older adults undergoing cancer surgery: A systematic review and meta-analysis.
Horiuchi K; Kuno T; Takagi H; Egorova NN; Afezolli D
J Geriatr Oncol; 2024 Apr; 15(3):101656. PubMed ID: 37940482
[TBL] [Abstract][Full Text] [Related]
2. Use of the G8 Geriatric Screening Tool in Surgical Head and Neck Cancer Patients Requiring Rehabilitation: A Multisite Investigation.
Palmer AD; Starmer H; Sathe N; Yao TJ; Bolognone RK; Edwards J; Crino C; Kizner J; Graville DJ
Ann Otol Rhinol Laryngol; 2024 Feb; 133(2):158-168. PubMed ID: 37551009
[TBL] [Abstract][Full Text] [Related]
3. Additional Value of Mini-Cog© in Urogeriatric Patients Concurrently Screened by G8 Scores.
Bouzan J; Willschrei P; Horstmann M
Medicines (Basel); 2023 Oct; 10(10):. PubMed ID: 37887263
[No Abstract] [Full Text] [Related]
4. Diagnostic accuracy of the geriatric screening tools G8 and modified G8 in older patients with lung cancer: A diagnostic performance study.
Bech D; Lietzen LW; Meldgaard P; Ryltoft AK; Ørum M
J Geriatr Oncol; 2024 Mar; 15(2):101645. PubMed ID: 37903667
[No Abstract] [Full Text] [Related]
5. Process evaluation of a G8 screening tool implementation in an outpatient oncology center.
Swartz K; Chapman A; Zhan T; Wen KY
J Geriatr Oncol; 2024 Jan; 15(1):101605. PubMed ID: 37633778
[No Abstract] [Full Text] [Related]
6. Editorial Comment from Dr Naito to The significance of G8 and other geriatric assessments in urologic cancer management: A comprehensive review.
Naito S
Int J Urol; 2024 May; ():. PubMed ID: 38699904
[No Abstract] [Full Text] [Related]
7. The G8 frailty screening tool and the decision-making process in older breast cancer patients.
Scheepers ERM; van der Molen LF; van den Bos F; Burgmans JP; van Huis-Tanja LH; Hamaker ME
Eur J Cancer Care (Engl); 2021 Jan; 30(1):e13357. PubMed ID: 33159382
[TBL] [Abstract][Full Text] [Related]
8. Use of the Geriatric-8 screening tool to predict prognosis and complications in older adults with head and neck cancer: A prospective, observational study.
Ishii R; Ogawa T; Ohkoshi A; Nakanome A; Takahashi M; Katori Y
J Geriatr Oncol; 2021 Sep; 12(7):1039-1043. PubMed ID: 33757718
[TBL] [Abstract][Full Text] [Related]
9. Predicting immune-related adverse events using a simplified frailty score in cancer patients treated with checkpoint inhibitors: A retrospective cohort study.
Olsson Ladjevardi C; Koliadi A; Rydén V; Inan El-Naggar A; Digkas E; Valachis A; Ullenhag GJ
Cancer Med; 2023 Jun; 12(12):13217-13224. PubMed ID: 37132258
[TBL] [Abstract][Full Text] [Related]
10. Frailty and checkpoint inhibitor toxicity in older patients with melanoma.
Bruijnen CP; Koldenhof JJ; Verheijden RJ; van den Bos F; Emmelot-Vonk MH; Witteveen PO; Suijkerbuijk KPM
Cancer; 2022 Jul; 128(14):2746-2752. PubMed ID: 35439334
[TBL] [Abstract][Full Text] [Related]
11. Utility of the Geriatric 8 for the Prediction of Therapy-Related Toxicity in Older Adults with Diffuse Large B-Cell Lymphoma.
Oiwa K; Fujita K; Lee S; Morishita T; Tsukasaki H; Negoro E; Ueda T; Yamauchi T
Oncologist; 2021 Mar; 26(3):215-223. PubMed ID: 33320984
[TBL] [Abstract][Full Text] [Related]
12. Definition and assessment of frailty in older patients: the surgical, anaesthesiological and oncological perspective.
Dottorini L; Turati L; Mattei L; Formenti P
Ecancermedicalscience; 2020; 14():1105. PubMed ID: 33082855
[TBL] [Abstract][Full Text] [Related]
13. Frailty screening in dermato-oncology practice: a modified Delphi study and a systematic review of the literature.
van Winden MEC; Garcovich S; Peris K; Colloca G; de Jong EMGJ; Hamaker ME; van de Kerkhof PCM; Lubeek SFK
J Eur Acad Dermatol Venereol; 2021 Jan; 35(1):95-104. PubMed ID: 32403174
[TBL] [Abstract][Full Text] [Related]
14. Beliefs About Advanced Cancer Curability in Older Patients, Their Caregivers, and Oncologists.
Loh KP; Mohile SG; Lund JL; Epstein R; Lei L; Culakova E; McHugh C; Wells M; Gilmore N; Mohamed MR; Kamen C; Aarne V; Conlin A; Bearden J; Onitilo A; Wittink M; Dale W; Hurria A; Duberstein P
Oncologist; 2019 Jun; 24(6):e292-e302. PubMed ID: 31015317
[TBL] [Abstract][Full Text] [Related]
15. The role of Geriatric screening tool (G8) in predicting side effect in older patients during therapy with aromatase inhibitor.
Dottorini L; Catena L; Sarno I; Di Menna G; Marte A; Novelli E; Rusca C; Bajetta E
J Geriatr Oncol; 2019 Mar; 10(2):356-358. PubMed ID: 30333087
[TBL] [Abstract][Full Text] [Related]
16. Predictive ability of the G8 screening test to determine probable sarcopenia and abnormal comprehensive geriatric assessment in older patients with solid malignancies.
Cavusoglu C; Tahtaci G; Dogrul RT; Ileri I; Yildirim F; Candemir B; Kizilarslanoglu MC; Uner A; Goker B
BMC Geriatr; 2021 Oct; 21(1):574. PubMed ID: 34666690
[TBL] [Abstract][Full Text] [Related]
17. The performance of three oncogeriatric screening tools - G8, optimised G8 and CARG - in predicting chemotherapy-related toxicity in older patients with cancer. A prospective clinical study.
Kotzerke D; Moritz F; Mantovani L; Hambsch P; Hering K; Kuhnt T; Yahiaoui-Doktor M; Forstmeyer D; Lordick F; Knödler M
J Geriatr Oncol; 2019 Nov; 10(6):937-943. PubMed ID: 31085136
[TBL] [Abstract][Full Text] [Related]
18. A Questionnaire Study to Assess the Value of the Vulnerable Elders Survey, G8, and Predictors of Toxicity as Screening Tools for Frailty and Toxicity in Geriatric Cancer Patients.
Hentschel L; Rentsch A; Lenz F; Hornemann B; Schmitt J; Baumann M; Ehninger G; Schuler M
Oncol Res Treat; 2016; 39(4):210-6. PubMed ID: 27160741
[TBL] [Abstract][Full Text] [Related]
19. Postmenopausal women with hormone receptor-positive breast cancer: balancing benefit and toxicity from aromatase inhibitors.
Ingle JN
Breast; 2013 Aug; 22 Suppl 2():S180-3. PubMed ID: 24074784
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
